$IMUC
EOM Pharmaceutical Holdings, Inc.

2014 Q2 Form 10-Q Financial Statement

#000156459014003403 Filed on August 08, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q2
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $970.0K $970.0K
YoY Change 0.0% 3.19%
% of Gross Profit
Research & Development $1.460M $1.210M
YoY Change 20.66% -44.74%
% of Gross Profit
Depreciation & Amortization $11.28K $10.84K
YoY Change 4.07% -5.26%
% of Gross Profit
Operating Expenses $2.427M $2.180M
YoY Change 11.32% -0.44%
Operating Profit -$2.427M -$2.182M
YoY Change 11.22% -30.3%
Interest Expense $230.0K $2.030M
YoY Change -88.67% -161.14%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$2.199M -$150.3K
YoY Change 1362.88% -97.67%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.199M -$150.3K
YoY Change 1362.88% -97.67%
Net Earnings / Revenue
Basic Earnings Per Share -$0.04 $0.00
Diluted Earnings Per Share -$0.04 $0.00
COMMON SHARES
Basic Shares Outstanding 57.92M 52.73M
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.66M $25.45M
YoY Change 0.83% 124.43%
Cash & Equivalents $25.66M $25.45M
Short-Term Investments
Other Short-Term Assets $970.0K $400.0K
YoY Change 142.5% -35.48%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $26.63M $25.85M
YoY Change 3.02% 116.14%
LONG-TERM ASSETS
Property, Plant & Equipment $50.00K $90.00K
YoY Change -44.44% -10.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $460.0K $241.6K
YoY Change 90.42% 2315.75%
Total Long-Term Assets $510.0K $330.0K
YoY Change 54.55% 230.0%
TOTAL ASSETS
Total Short-Term Assets $26.63M $25.85M
Total Long-Term Assets $510.0K $330.0K
Total Assets $27.14M $26.18M
YoY Change 3.67% 117.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $620.0K $330.0K
YoY Change 87.88% -42.11%
Accrued Expenses $500.0K $490.0K
YoY Change 2.04% 8.89%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.120M $820.0K
YoY Change 36.59% -19.61%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.260M $2.310M
YoY Change -45.45% -73.45%
Total Long-Term Liabilities $1.260M $2.310M
YoY Change -45.45% -73.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.120M $820.0K
Total Long-Term Liabilities $1.260M $2.310M
Total Liabilities $2.380M $3.130M
YoY Change -23.96% -67.8%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $24.76M $23.05M
YoY Change
Total Liabilities & Shareholders Equity $27.14M $26.18M
YoY Change 3.67% 117.08%

Cashflow Statement

Concept 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income -$2.199M -$150.3K
YoY Change 1362.88% -97.67%
Depreciation, Depletion And Amortization $11.28K $10.84K
YoY Change 4.07% -5.26%
Cash From Operating Activities -$2.710M -$1.910M
YoY Change 41.88% -42.3%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$30.00K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 -$30.00K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.330M 3.300M
YoY Change 0.91% 202.75%
NET CHANGE
Cash From Operating Activities -2.710M -1.910M
Cash From Investing Activities 0.000 -30.00K
Cash From Financing Activities 3.330M 3.300M
Net Change In Cash 620.0K 1.360M
YoY Change -54.41% -161.26%
FREE CASH FLOW
Cash From Operating Activities -$2.710M -$1.910M
Capital Expenditures $0.00 -$30.00K
Free Cash Flow -$2.710M -$1.880M
YoY Change 44.15% -43.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q2 imuc Earning Before Dividend Adjustment Per Share Basic And Diluted
EarningBeforeDividendAdjustmentPerShareBasicAndDiluted
0.00
CY2014Q2 imuc Earning Before Dividend Adjustment Per Share Basic And Diluted
EarningBeforeDividendAdjustmentPerShareBasicAndDiluted
-0.04
imuc Earning Before Dividend Adjustment Per Share Basic And Diluted
EarningBeforeDividendAdjustmentPerShareBasicAndDiluted
-0.09
imuc Earning Before Dividend Adjustment Per Share Basic And Diluted
EarningBeforeDividendAdjustmentPerShareBasicAndDiluted
-0.10
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-403588
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-40955
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
128546
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5316372
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4117822
imuc Proceeds From Issuance Of Common Stock And Warrants From Underwritten Public Offering
ProceedsFromIssuanceOfCommonStockAndWarrantsFromUnderwrittenPublicOffering
2289316
imuc Proceeds From Issuance Of Common Stock And Warrants From Underwritten Public Offering
ProceedsFromIssuanceOfCommonStockAndWarrantsFromUnderwrittenPublicOffering
404208
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-150000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3334316
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3387977
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1985256
imuc Common Stock Issued Through Controlled Equity Offering
CommonStockIssuedThroughControlledEquityOffering
2289316
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
us-gaap Depreciation
Depreciation
23917
us-gaap Depreciation
Depreciation
21684
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-3817
us-gaap Share Based Compensation
ShareBasedCompensation
312650
us-gaap Share Based Compensation
ShareBasedCompensation
344074
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
203265
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-307594
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-239131
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3600
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
34441
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
400
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3200
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-34441
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1045000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
84131
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3049638
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-764286
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26216668
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25452382
us-gaap Interest Paid
InterestPaid
us-gaap Interest Paid
InterestPaid
us-gaap Income Taxes Paid
IncomeTaxesPaid
us-gaap Income Taxes Paid
IncomeTaxesPaid
imuc Warrant Liability Converted To Additional Paid In Capital Upon Exercise
WarrantLiabilityConvertedToAdditionalPaidInCapitalUponExercise
1145660
imuc Common Stock Issued For License Rights
CommonStockIssuedForLicenseRights
75000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:12pt;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Use of Estimates<font style="font-style:normal;"> &#8211; The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions about the future outcome of current transactions which may affect the reporting and disclosure of these transactions. Accordingly, actual results could differ from those estimates used in the preparation of these financial statements.</font></p></div>
CY2014Q2 imuc Working Capital
WorkingCapital
25505472
CY2013Q4 imuc Working Capital
WorkingCapital
27007377
imuc Maturity Period Of Highly Liquid Instruments To Be Considered As Cash Equivalents Maximum
MaturityPeriodOfHighlyLiquidInstrumentsToBeConsideredAsCashEquivalentsMaximum
P90D
CY2014Q2 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
22420397
CY2013Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
25913893
us-gaap Property Plant And Equipment Estimated Useful Lives
PropertyPlantAndEquipmentEstimatedUsefulLives
generally three to five years
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0218
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.00074
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y6M
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y6M15D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.953
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.905
imuc Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeitures Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeituresRate
0.00
imuc Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeitures Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeituresRate
0.00
CY2014Q2 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
56587180
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
0
CY2014Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2014Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19710598
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21992841
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
176886
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
185375
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
131157
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
118933
CY2014Q2 us-gaap Depreciation
Depreciation
11283
CY2013Q2 us-gaap Depreciation
Depreciation
10842
CY2006Q4 imuc Stock Issued During Period Shares Issued For Upfront Licensing Fee
StockIssuedDuringPeriodSharesIssuedForUpfrontLicensingFee
694000
CY2006Q4 imuc Payment For Upfront Licensing Fee
PaymentForUpfrontLicensingFee
62000
CY2008Q4 imuc Funding From Equity For Milestone Minimum
FundingFromEquityForMilestoneMinimum
5000000
imuc Payment To Related Party For Clinical Trial
PaymentToRelatedPartyForClinicalTrial
166660
CY2008Q2 imuc Stock Issued During Period Shares Issued For Additional Licensing Fee
StockIssuedDuringPeriodSharesIssuedForAdditionalLicensingFee
100000
CY2011Q3 imuc Amount Of Funding From Equity Minimum After Amendment
AmountOfFundingFromEquityMinimumAfterAmendment
5000000
CY2010Q4 imuc Amount Of Funding From Equity Minimum After Amendment
AmountOfFundingFromEquityMinimumAfterAmendment
2500000
us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
210856
us-gaap Related Party Transaction Other Revenues From Transactions With Related Party
RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
446142
imuc Extended Term Of Agreement
ExtendedTermOfAgreement
2014-03-31
imuc Period Within Effective Date Of License Agreement
PeriodWithinEffectiveDateOfLicenseAgreement
P30D
imuc Nonrefundable And Noncreditable License And Maintenance Fee
NonrefundableAndNoncreditableLicenseAndMaintenanceFee
P12M
CY2014Q2 us-gaap Rental Properties
RentalProperties
8063
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
354000
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
187371
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
202425
CY2014Q2 imuc Common Stock Shares Purchased Private Placement Warrant
CommonStockSharesPurchasedPrivatePlacementWarrant
2854196
CY2012Q1 imuc Common Stock Warrants Exercise Price Private Placement
CommonStockWarrantsExercisePricePrivatePlacement
1.41
CY2012Q1 imuc Common Stock Shares Issuable Private Placement Warrants
CommonStockSharesIssuablePrivatePlacementWarrants
4744718
CY2012Q1 imuc Warrants Exercisable Period After Initial Issuance
WarrantsExercisablePeriodAfterInitialIssuance
P5Y
imuc Common Stock Warrants Exercise Price Private Placement
CommonStockWarrantsExercisePricePrivatePlacement
1.12
CY2010Q2 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
834455
CY2012Q1 imuc Adjusted Exercise Price Of Warrants
AdjustedExercisePriceOfWarrants
1.87
CY2012Q4 imuc Common Stock Shares Purchased Private Placement Warrant
CommonStockSharesPurchasedPrivatePlacementWarrant
2823670
imuc Charge To Financing Expense
ChargeToFinancingExpense
368524
CY2012Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
2852880
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
24600
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
0
imuc Warrants Exercised
WarrantsExercised
0
imuc Warrants Exercised
WarrantsExercised
1145660
imuc Warrant Liability Gain Loss Included In Earnings
WarrantLiabilityGainLossIncludedInEarnings
-166933
imuc Warrant Liability Gain Loss Included In Earnings
WarrantLiabilityGainLossIncludedInEarnings
-604171
imuc Warrants Liability Transfers Net
WarrantsLiabilityTransfersNet
0
imuc Warrants Liability Transfers Net
WarrantsLiabilityTransfersNet
0
CY2013Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
2311391
CY2014Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2013Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.34
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.34
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.06
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.06
imuc Change In Fair Value Of Warrant Liability For Income Taxes
ChangeInFairValueOfWarrantLiabilityForIncomeTaxes
-0.01
imuc Change In Fair Value Of Warrant Liability For Income Taxes
ChangeInFairValueOfWarrantLiabilityForIncomeTaxes
0.05
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.41
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.35
us-gaap Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
0.00
us-gaap Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
0.00
CY2014Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
17935529
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
15759274
CY2014Q2 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
2146047
CY2013Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
2020987
CY2014Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
20081576
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
17780261
CY2014Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
imuc Net Operating Losses Expire Date
NetOperatingLossesExpireDate
expire in 2022 and 2016

Files In Submission

Name View Source Status
0001564590-14-003403-index-headers.html Edgar Link pending
0001564590-14-003403-index.html Edgar Link pending
0001564590-14-003403.txt Edgar Link pending
0001564590-14-003403-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
imuc-10q_20140630.htm Edgar Link pending
imuc-20140630.xml Edgar Link completed
imuc-20140630.xsd Edgar Link pending
imuc-20140630_cal.xml Edgar Link unprocessable
imuc-20140630_def.xml Edgar Link unprocessable
imuc-20140630_lab.xml Edgar Link unprocessable
imuc-20140630_pre.xml Edgar Link unprocessable
imuc-ex31_2014063051.htm Edgar Link pending
imuc-ex31_2014063052.htm Edgar Link pending
imuc-ex32_2014063053.htm Edgar Link pending
imuc-ex32_2014063054.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending